Pyridostigmine Bromide
- Product NDC
- 64980-220
- 11-digit product format
- 649800220
- Labeler code
- 64980
- Product ID
- 64980-220_34812796-3684-4619-a70c-fc93e22d123a
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Pyridostigmine Bromide
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Rising Pharma Holdings, Inc.
- Application
- ANDA205464
- Marketing category
- ANDA
- Marketing start
- 2017-08-15
- Substance
- PYRIDOSTIGMINE BROMIDE
- Active strength
- 180 mg/1
- Pharmacologic classes
- Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Pyridostigmine Bromide
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| PYRIDOSTIGMINE BROMIDE | 180 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | KVI301NA53 |
| Rxcui | 903847 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 64980-220-03 | Pyridostigmine Bromide | 30 in 1 BOTTLE | TABLET | 30 | | 4 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 64980-220 | PYRIDOSTIGMINE BROMIDE TABLET [RISING PHARMACEUTICALS, INC.] | 3 | Current NDC, Legacy NDC, 1 package rows | 20221108_f7a75639-a23a-4847-a962-c091c61947f0.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 64980-220-03 | 64980022003 | 30 TABLET in 1 BOTTLE (64980-220-03) | 30 tablet | 2017-08-15 | 0000-00-00 | No | No | Current |